These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9219019)

  • 1. Enhancing cognition in the intellectually intact.
    Whitehouse PJ; Juengst E; Mehlman M; Murray TH
    Hastings Cent Rep; 1997; 27(3):14-22. PubMed ID: 9219019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition-enhancing drugs.
    Mehlman MJ
    Milbank Q; 2004; 82(3):483-506, table of contents. PubMed ID: 15330974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive enhancement: promises and perils.
    Hyman SE
    Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nootropes (cognition enhancers) and neuroprotectors].
    Vornin TA; Seredenin SB
    Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research subject loses case against physician, IRB, and hospital.
    Maloney DM
    Hum Res Rep; 1995 Feb; 10(2):4-5. PubMed ID: 11654160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Can intelligence be increased with drugs?].
    Virsu V
    Duodecim; 2000; 116(15):1525-6. PubMed ID: 12001471
    [No Abstract]   [Full Text] [Related]  

  • 7. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Federal regulation of Ritalin in the treatment of hyperactive children.
    Padway L
    Ecol Law Q; 1978; 7(2):457-95. PubMed ID: 11664992
    [No Abstract]   [Full Text] [Related]  

  • 10. Abortion politics, science, and research ethics: take down the wall of separation.
    Fletcher JC
    J Contemp Health Law Policy; 1992; 8():95-121. PubMed ID: 11645741
    [No Abstract]   [Full Text] [Related]  

  • 11. Obtaining "informed consent": controversy over radiation tests focuses attention on rules for human subjects.
    Wheeler DL
    Chron High Educ; 1994 Jan; 40():8-9, 16. PubMed ID: 11658067
    [No Abstract]   [Full Text] [Related]  

  • 12. Experts urge smart thinking on cognitive enhancers.
    Morris K
    Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
    [No Abstract]   [Full Text] [Related]  

  • 13. Children's capacities to decide about participation in research.
    Weithorn LA
    IRB; 1983; 5(2):1-5. PubMed ID: 11653517
    [No Abstract]   [Full Text] [Related]  

  • 14. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioethical catch-22: the moratorium on federal funding of fetal tissue transplantation research and the NIH revitalization amendments.
    Maroney HM
    J Contemp Health Law Policy; 1993; 9():485-519. PubMed ID: 10126947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical and legal aspects of teratogenic medications: the case of isotretinoin.
    Moskop JC; Smith ML; De Ville K
    J Clin Ethics; 1997; 8(3):264-78. PubMed ID: 9436085
    [No Abstract]   [Full Text] [Related]  

  • 17. Protecting research subjects after consent: the case for the "research intermediary.
    Reiser SJ; Knudson P
    IRB; 1993; 15(2):10-1. PubMed ID: 11651567
    [No Abstract]   [Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of involving psychiatrically impaired persons in research.
    DeRenzo EG
    IRB; 1994; 16(6):7-9, 11. PubMed ID: 11659990
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating the public with risk communications: a public health perspective.
    Fischhoff B
    Sci Technol Human Values; 1987; 12(3 and 4):13-9. PubMed ID: 11649904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.